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Abstract 
Vitamin  E  (VE)  can  effectively  prevent  occurrence  of  lung  cancer  caused  by  passive 
smoking in mice. However, whether VE prevents smoking-induced cytotoxicity remains 
unclear. In this study, a primary culture of embryonic lung cells (ELCs) was used to ob-
serve the cytotoxic effects of cigarette smoke extract (CSE), including its influence on cell 
survival, cell cycle, apoptosis, and DNA damage, and also to examine the effects of VE 
intervention on CSE-induced cytotoxicity. Our results showed that CSE could signifi-
cantly inhibit the survival of ELCs with dose- and time-dependent effects. Furthermore, 
CSE clearly disturbed the cell cycle of ELCs by decreasing the proportion of cells at the S 
and G2/M phases and increasing the proportion of cells at the G0/G1 phase. CSE pro-
moted cell apoptosis, with the highest apoptosis rate reaching more than 40%. CSE also 
significantly caused DNA damage of ELCs. VE supplementation could evidently inhibit 
or  reverse  the  cytotoxic  effects  of  CSE  in  a  dose-  and  time-dependent  manner.  The 
mechanism of CSE effects on ELCs and that of VE intervention might involve the mito-
chondrial pathway of cytochrome c-mediated caspase activation. Our study validate that 
VE plays a clearly protective effect against CSE-induced cytotoxicity in mouse embryonic 
lung cells. 
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Introduction 
Cigarette  smoking  is  the  main  cause  of  lung 
cancer and pulmonary emphysema [1, 2]. There were 
a number of passive smoking populations in China 
[3], the investigation results indicated that sidestream 
smoke which contains higher concentrations of haz-
ardous  chemicals  [4]  might  be  more  harmful  [5,  6] 
than  mainstream  smoke.  The  harmful  effects  of 
smoking and passive smoking are mainly correlated 
with oxidative stress damage caused by the oxidative 
substances in cigarette smoke [7, 8]. Although epide-
miological  studies  present  contradictory  views  re-
garding the preventive effects of antioxidant vitamin 
E (VE) supplements on smoking-induced lung cancer 
[9,  10],  animal  experiments  findings  have  demon-
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strated that VE can effectively prevent passive smok-
ing-induced lung cancer in mice [11, 12]. Although the 
pathogenesis  of  lung  cancer  caused  by  cigarette 
smoke appears to be complex, it is the major pathway 
that  exposure  to  cigarette  smoke  causes  lung  cells 
DNA damage or apoptosis [13-15]. Recent researches 
indicated  that  cigarette  smoke  extract  (CSE)  could 
produce  a  clear  cytotoxic  effect  [13-19];  however, 
whether  VE  prevents  CSE-induced  cytotoxicity  and 
its mechanisms remain unclear. 
In  this  study,  an  embryonic  lung  cells  (ELCs) 
model was used to observe the influence of CSE on 
cell survival, cell cycle, apoptosis, and DNA damage 
and VE intervention in CSE-induced cytotoxicity; we 
also explored the mechanisms of CSE-induced cyto-
toxicity  and  VE  intervention.  We  believe  that  this 
study  will  contribute  to  investigate  the  underlying 
mechanism of the preventive effect of VE on smok-
ing-induced lung cancer.  
Materials and Methods 
Reagents 
VE  (DL-alpha-tocopherol)  was  obtained  from 
Sigma  (St.  Louis,  MO,  USA).  Cigarettes  were  pur-
chased from the local supermarket (Hongmei Brand; 
tar content, 15 mg; and nicotine content, 1.2 mg per 
cigarette). The nicotine standard was obtained from 
Merck  Biosciences  (Hohenbrunn,  Germany). 
RPMI-1640  medium,  dimethylsulfoxide  (DMSO),  ri-
bonuclease A (Rnase A), and trypsin were obtained 
from Invitrogen Corporation (N. Y. USA). 
Mouse ELCs preparation and culture 
ELCs were isolated from Swiss mouse embryos 
and cultured as described previously [20, 21]. Briefly, 
the embryos lungs were removed on the 13th day of 
gestation.  The  tissue  pieces  were  shaken  in  phos-
phate-buffered saline (PBS) containing 0.25% trypsin 
on a rotary shaker at 37°C for 20 min. Pipette tissue 
pieces several times until a single cell suspension was 
obtained. After standing for 1 min, the cell suspension 
was centrifuged at 1000 revolutions per minute for 5 
min. The cell pellets were resuspended in RPMI-1640 
medium supplemented with 10% fetal bovine serum 
(FBS),  penicillin  (100  units/ml),  and  streptomycin 
(100  μg/ml)  to  obtain  ELCs  suspension.  The  ELCs 
were plated at a concentration of 2 × 106 cells/ml and 
incubated at 37°C in 5% CO2, and were observed and 
photographed at the logarithmic growth phase under 
inverted  microscope  (Olympus)  as  described  previ-
ously [20, 21]. The ELCs could grow for more than 10 
consecutive passages.  
CSE preparation and nicotine concentration de-
termination 
The CSE was prepared as described previously 
[17, 22-24]. Briefly, the smoke of four lit cigarettes was 
collected by a peristaltic pump apparatus into 15 ml of 
RPMI-1640  medium.  By  bubbling  the  smoke  in  the 
medium,  CSE  stock  solution  was  obtained,  concen-
tration  of  nicotine  in  the  CSE  stock  solution  was 
measured  by  high-performance  liquid  chromatog-
raphy  (HPLC)  method  at  the  Central  Lab,  Nankai 
University,  and  the  concentration  of  nicotine  was 
about 70000 ng/L in CSE stock solution, and then CSE 
stock  solution  was  filtered  through  a  0.22-μm-pore 
size  filter  and  diluted  to  the  desired  concentration 
with cell medium. 
Effects of CSE on survival of ELCs and VE inter-
vention  
The ELCs at the logarithmic growth phase were 
treated  with  0.25%  trypsin  to  prepare  a  single  cell 
suspension. The cells were adjusted to a concentration 
of 1 × 105 cell/ml and seeded 200 µl cell suspension to 
each well in a 96-well plate, and 3 parallel wells were 
set for each group treated with various concentrations 
of CSE [70000 ng/L (CSE stock solution), 400 ng/L, 
200 ng/L, 100 ng/L, and 12.5 ng/L as the equivalent 
to  nicotine].  There  was  no  nicotine  in  the  control 
group. The cells were incubated for 24 h, 48 h, and 72 
h at 37°C under an atmosphere consisting of 5% CO2 
and 95% air. Four hours before the end of the incuba-
tion, 20 µl of 5 mg/ml MTT was added to each well, 
and the cells were solubilized with 100 µl DMSO.  
The  optical  density  (OD)  of  each  well  was 
measured using ELISA plate reader (Wellscan MK3, 
Labsystems  Dragon)  with  a  test  wavelength  of  492 
nm. The cell survival rate (SR) was determined by the 
following equation: 
SR = (OD value in treated groups/OD value in con-
trol) × 100%. 
For VE intervention, VE treatment was prepared 
as described previously  [25, 26], VE stock solutions 
were prepared in ethanol, various concentrations of 
VE (1 μmol/L, 25 μmol/L, 50 μmol/L, 100 μmol/L 
and 200 μmol/L) were added to the cell medium 2 h 
before CSE (200 ng/L as the equivalent to nicotine) 
treatment. The survival rate was determined using the 
MTT method as described above. 
Effects of CSE on cell cycle and apoptosis of ELCs 
and VE intervention 
The ELCs at the logarithmic growth phase were 
seeded in a 6-well plate and incubated for 24 h at 37°C 




treated  with  various  concentrations  of  CSE  [70000 
ng/L(CSE  stock  solution),  400  ng/L,  200  ng/L,  100 
ng/L, and 12.5 ng/L as the equivalent to nicotine] and 
incubated  for  a  further  48  h.  The  morphological 
changes  were  recorded  with  an  invert  microscope 
equipped with a charge-coupled device (CCD) cam-
era. The CSE-treated cells were trypsinized and ad-
justed to a concentration of 1×106 cells/ml. The cells 
were washed with PBS, resuspended in 100 µl of 1 
mg/ml Rnase A, and incubated at 37°C for 30 min for 
RNA digestion, followed by staining with 400 µl of 50 
µg/ml propidium iodide ( PI ) for 10 min in the dark 
for the cell cycle and apoptosis assays. Flow cytome-
try  was  performed  using  a  fluorescence-activated 
cell-sorting  (FACS)  Calibur  flow  cytometer  (Becton 
Dickinson). Data were analyzed using ModiFit LT for 
Mac V 3.0 software (Becton Dickinson), and the per-
centage of G0/G1, S, G2/M, and apoptotic cells were 
determined. For VE intervention, various concentra-
tions of VE (1 μmol/L, 25 μmol/L, 50 μmol/L, 100 
μmol/L and 200 μmol/L) were added to the medium 
2 h before CSE (200 ng/L as the equivalent to nicotine) 
treatment and analysis was performed using FACS. 
DNA damage caused by CSE and VE intervention 
The single-cell gel electrophoresis (or comet as-
say)  was  used  to  detect  DNA  damage  [27].  Briefly, 
after treatment respectively with or without CSE (200 
ng/L as the equivalent to nicotine) in presence or ab-
sence of VE (100 μmol/L) in 6-well plates for 30h, cells 
were harvested and washed twice with PBS. An ali-
quot  of  8μl  of  the  cells  suspension  (2×105 cells/ml) 
was  mixed  with  80  μl  of  0.75%  low  melting-point 
agarose at 37°C and rapidly spreaded on microscope 
slides  pre-coated  with  0.5%  normal  melting-point 
agarose, the slides were covered with cover slips re-
spectively and allowed to solidify on ice. After 10 min, 
the slides were placed in a freshly made cold lysing 
solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, pH 
10, which 10% DMSO and 1% Triton X-100 had been 
added immediately prior to use) for 3 h at 4°C. After a 
ice-cold  PBS  washing  for  3  times,  the  slides  were 
placed in electrophoresis buffer (300 mM NaOH and 1 
mM EDTA, pH 13) for 30 min to allow unwinding of 
the  DNA  and  DNA  breakage  at  alkali-labile  sites. 
Electrophoresis was conducted in the same buffer (300 
mA, 25V) for 20 min. The slides were washed in neu-
tralization buffer (0.4 M Tris, pH 7.5) 3 times for 5 min 
each, fixation in ethanol for 40 min was followed and 
finally samples were stained with PI (5 μg/ml) for 15 
min. The comets were analyzed at 10×40 magnifica-
tions with a fluorescence microscope (Olympus BX51) 
attached to a CCD video camera equipped with a G 
excitation filter and connected to a personal comput-
er-based  image  analysis  system,  Metaph  series  4.5. 
Fifty cells were randomly selected from each sample 
and the fraction of DNA tail was measured. DNA tail 
length was determined to assess the extent of DNA 
damage. 
Caspase-3 activity assay 
Caspase-3  activity  was  determined  using  a 
commercially available caspase-3 assay kit (Keygen); 
the manufacturer’s instructions and the methods de-
scribed in a previous report [28] were followed. This 
assay is based on the ability of the activated caspase-3 
enzyme to cleave the chromophore from its substrate. 
After treatment respectively with or without CSE (200 
ng/L as the equivalent to nicotine) in presence or ab-
sence of VE (100 μmol/L) in dishes for 30 h, cells were 
harvested and washed twice with PBS, mixed with 50 
μl ice-cold lysis buffers, and placed on ice for 20 min. 
Lysates were then centrifuged at 10,000 × g for 1 min 
at 4°C. The supernatants were collected, and the con-
centration of total proteins was adjusted to 2 μg/μl. 
Next,  50  μl  of  the  supernatants  were  transferred  to 
microplates and mixed with 50 μl 2× reaction buffers. 
5 μl colorimetric caspase-3 substrates were added into 
each well of microplates, then the plates were incu-
bated for 4 h at 37°C. Cleavage of the peptide sub-
strate was monitored at 405 nm using an ELISA plate 
reader (Labsystems Dragon). Cell enzymatic activity 
of caspase-3 was expressed as the OD405. 
Western blotting 
After treatment respectively with or without CSE 
(200 ng/L as the equivalent to nicotine) in presence or 
absence of VE (100 μmol/L) in 6-well plates for 30 h, 
cells were harvested and washed twice with PBS. For 
Bax and Bcl-2 detection, total cell proteins were re-
covered  according  to  a  previous  method  [29].  Cells 
were lysed in RIPA buffer (50 mM Hepes, 150 mM 
NaCl,  1%  Triton  X-100,  5  mM  EGTA,  50  mM 
β-glycerophosphate,  20  mM  NaF,  1  mM  Na3VO4,  2 
mM  phenylmethylsulfonyl  fluoride,  10  μg/ml 
leupeptin, and 10 μg/ml aprotinin, pH 7.5). After in-
cubation on ice for 30 min, extracts were clarified by 
centrifugation at 10,000 × g for 30 min at 4°C; the su-
pernatants were subjected to western blot analysis for 
Bax  and  Bcl-2.  For  cytochrome  c  detection,  cytosol 
proteins  were  recovered  according  to  a  previous 
method [30]. Cells were lysed in a buffer described 
previously (250 mM sucrose; 20 mM Hepes-KOH, pH 
7.5; 10 mM KCl; 1.5 mM MgCl2; 1 mM EDTA; 1 mM 
EGTA; 1 mM dithiothreitol; and 0.1 mM phenylme-
thylsulfonyl fluoride). The lysates were then homog-
enized and centrifuged 3 times at 3000 × g for 10 min 




tants were subjected to western blot analysis for cy-
tochrome c. The protein content of each supernatant 
was  determined  using  the  Bradford  assay.  The  su-
pernatant  solution  was  mixed  with  5×  SDS-loading 
buffer, following treatment in a water bath at 100°C 
for 10 min. For western blot analysis, equal amounts 
of  total  proteins  (20  μg)  were  separated  by  12% 
SDS-PAGE and then transferred and blotted onto a 
PVDF membrane (Millipore Corporation, Massachu-
setts, U.S.A.). Immunoblots were analyzed using the 
following  specific  primary  antibodies  (Santa  Cruz 
Biotechnology,  Inc.,  California,  U.S.A.):  anti-Bax 
(sc-7480),  anti-Bcl-2  (sc-7382),  anti-cytochrome  c 
(sc-13156), and anti-actin (sc-1616-R). After exposure 
to horseradish  peroxidase-conjugated secondary an-
tibody  (ZB-2301,  Zhongshan  Goldenbridge  Biotech-
nology,  Co.,  LTD.,  Beijing,  China)  for  1  h,  protein 
bands were visualized using Western Blotting Lumi-
nol Reagent (sc-2048, Santa Cruz Biotechnology, Inc., 
California, U.S.A.).  
Statistical analysis 
All data were presented as mean ± SD. Statistical 
analysis was performed using one-way ANOVA (LSD 
test). We used the SPSS 11.5 program for the statistical 
analysis. A P-value of < 0.05 was considered statisti-
cally significant. 
Results 
Effects of CSE on survival, cell cycle, and apop-
tosis of ELCs 
Effects of CSE on survival of ELCs 
The inhibitory effects on ELCs increased with an 
increase in the CSE concentration and treatment time, 
indicating dose- and time-dependency of the inhibi-
tory effects. The CSE with a nicotine concentration of 
200 ng/L or higher produced clear inhibitory effects 
on the growth of ELCs at the 24 h, 48 h, and 72 h time 
points (Figure 1). 
Effects of CSE on cell cycle of ELCs 
The  proportion  of  ELCs  in  the  S  and  G2/M 
phases decreased significantly in the groups with CSE 
containing 200 ng/L or higher concentrations of nico-
tine treatments compared to that in the control group 
(P < 0.05, P < 0.01). There was a significant increase in 
the  proportion  of  ELCs  in  the  G0/G1  phase  in  the 
groups treated with 200 ng/L or higher concentration 
of nicotine compared to that in the control group (P < 
0.01). The above results suggested that the CSE de-
creased  the  proportion  of  cells  in  the  S  and  G2/M 
phases  and  mainly  arrested  the  cells  in  the  G0/G1 
phase (Figure 2).  
 
Figure 1. Effects of CSE on survival of ELCs (OD, mean 
±S, and n = 3). The CSE could inhibit the cell survival and 
proliferation  of  the  ELCs,  indicating  dose-  and 
time-dependency  of  the  inhibitory  effect.  *  P  <  0.05  vs 
control group. R=-0.930, -0.977, -0.986 for 24 h, 48 h and 72 
h respectively, P <0.05 (dose-response). Con: control, CSE1: 
12.5 ng/L, CSE2: 100 ng/L, CSE3: 200 ng/L, CSE4: 400 ng/L, 
CSE5: 70,000 ng/L as the equivalent to nicotine. 
 
 
Figure 2. Effects of CSE on cell cycle of ELCs ( %, mean 
±SD, n = 3). CSE decreased the proportion of ELCs in the S 
and G2/M phases while increased that in the G0/G1 phase of 
cell cycle. * P < 0.05, # P < 0.01 vs control group. Con: 
control, CSE1: 12.5 ng/L, CSE2: 100 ng/L, CSE3: 200 ng/L, 
CSE4: 400 ng/L, CSE5: 70,000 ng/L as the equivalent to 
nicotine. 
 
Effects of CSE on apoptosis of ELCs 
The  apoptosis  rate  of  ELCs  treated  with  CSE 
containing 100 ng/L nicotine or higher concentrations 
increased significantly compared to that of the control 




apoptotic and shed cells gradually increased with the 
increase of CSE concentrations (Figure 3 B, C). The 
above results illustrated that CSE could promote the 







Figure  3.  Effects  of  CSE  on  ELCs  apoptosis.  (A)  Cell 
apoptosis rate was determined by the FACS analysis. CSE1: 
12.5 ng/L, CSE2: 100 ng/L, CSE3: 200 ng/L, CSE4: 400 ng/L, 
CSE5:  70,000  ng/L  as  the  equivalent  to  nicotine.  The 
apoptosis rate of the ELCs treated with CSE with 100 or 200 
ng/L nicotine significantly increased compared to that of 
the control group , furthermore, the apoptosis rate of the 
ELCs in CSE4 and CSE5 group reached 20% – 40%, showing a 
significant increase compared to that of the control group. * 
P < 0.05 vs control group, ** P < 0.01 vs control group. (B) 
Morphological  analysis  under  a  light  microscope.  The 
number of shed cells clearly increased in CSE2 group, and 
almost all cells were shed in CSE5 group. (C) The repre-
sentative pictures for Cell apoptosis rate determined by the 
FACS  analysis.  A  hypodiploid  peak  could  be  seen  in  the 
sub-G0/G1 region, and it reflected an apoptotic state of the 
cells.  VE:  100  μmol/L
  VE  treatment  group,  CSE:  CSE 
(equivalent to 200 ng/L nicotine) treatment group, CSE+VE: 
100  μmol/L
 VE  +  CSE  (equivalent  to  200  ng/L  nicotine) 
treatment group. 
 
DNA damage of ELCs caused by CSE 
The length of the DNA comet tail in ELCs ex-
posed to CSE (200 ng/L as the equivalent to nicotine) 
was significantly longer than that in the control group 
(P<0.05) (Figure 4 A), which was also confirmed by 
morphological  analysis  under  fluorescence  micro-
scope (Figure 4 B). It is suggested that CSE at the ex-
perimental concentration was genotoxic and contrib-
uted to DNA strand breaks.  
Preventive effects of VE on CSE-induced ELCs 
cytotoxicity  
Preventive effects of VE on CSE-induced inhibitory 
effects on ELCs survival 
At  a  dose  of  100  μmol/L or  higher, VE  could 
clearly prevent the inhibitory effects of CSE treatment 
at 24 h(P < 0.05); at doses 50 μmol/L and 25 μmol/L, 
VE  clearly  eliminated  the  inhibitory  effect  of  CSE 
treatments  at 48 h and 72 h, respectively(P < 0.05). 
ELCs survival in the groups treated with 25 μmol/L 
or higher doses of VE was significantly higher than 
that in the CSE group at the 72 h time point (P < 0.05). 
The above results suggested that VE could prevent or 
reverse CSE-induced inhibition in ELCs survival, in-
dicating dose- and time-dependency of the preventive 
effect, however, VE alone neither promote nor inhibit 
ELCs survival (Figure 5). 
Intervention of VE on CSE induced changes in cell 
cycle of ELCs 
The intervention effect of VE was considerably 
significant at a dose of 100 μmol/L or above (P < 0.01). 
The proportion of ELCs in the G0/G1 phase was re-




μmol/L or above VE treatment groups compared to 
that of the control group (P > 0.05). The proportion of 
cells in the S and G2/M phases was clearly higher in 
50 μmol/L or higher VE treatment groups than that of 
the CSE group (P < 0.05), and showed no significant 
difference compared to that of the control group (P > 
0.05). The above results suggested that VE could sig-
nificantly prevent CSE-induced disturbance of the cell 
cycle of ELCs, showing a dose-dependent correlation, 
however, VE alone did not induce any changes in cell 




Figure 4. CSE-induced ELCs DNA damage and VE inter-
vention. (A) DNA damage expressed as the length of DNA 
tail (μm) was determined by the comet assay. Data repre-
sented the mean ± SD of six independent experiments. * P < 
0.05 vs control group, # P < 0.05 vs CSE group. (B) Mor-
phological  analysis  under  a  fluorescence  microscope 
(Olympus BX51). VE: 100 μmol/L
 VE treatment group, CSE: 
CSE  (equivalent  to  200  ng/L  nicotine)  treatment  group, 
CSE+VE: 100 μmol/L
 VE + CSE (equivalent to 200 ng/L nic-
otine) treatment group. 
 
Figure  5.  Preventive  effects  of  VE  on  CSE-induced  in-
hibitory effects on ELCs survival (OD,  mean ±SD,  and n = 
3). VE could prevent or reverse CSE-induced inhibition on 
ELCs survival, indicating dose- and time-dependency of the 
preventive effects. * P < 0.05 vs control group. 
# P < 0.05 vs 
CSE  group.  Con:  control,  VE:  100  μmol/L
  VE  treatment 
group, CSE: CSE (equivalent to 200 ng/L nicotine) treat-
ment group, T1: 1.0 μmol/L
 VE + CSE (equivalent to 200 
ng/L nicotine) treatment group, T2: 25.0 μmol/L
 VE + CSE 
(equivalent to 200 ng/L nicotine) treatment group, T3: 50 
μmol/L
 VE + CSE (equivalent to 200 ng/L nicotine) treat-
ment group, T4: 100 μmol/L
 VE + CSE (equivalent to 200 
ng/L nicotine) treatment group, T5: 200 μmol/L
 VE + CSE 
(equivalent to 200 ng/L nicotine) treatment group. 
 
 
Figure 6. Intervention of VE in CSE-induced change in 
cell cycle of ELCs (%, mean ±SD, and n = 3). VE could 
significantly prevent CSE-induced disturbance of the cell 
cycle  of  ELCs,  showing  a  dose-dependent  correlation, 
however, VE alone did not induce any change in cell cycle of 
ELCs. * P < 0.05, $ P < 0.01 vs control group, 
# P < 0.05, 
@ P < 
0.01 vs CSE group. Con: control, VE: 100 μmol/L
 VE treat-
ment  group,  CSE:  CSE  (equivalent  to  200  ng/L  nicotine) 
treatment group, T1: 1.0 μmol/L




200 ng/L nicotine) treatment group, T2: 25.0 μmol/L
 VE + 
CSE (equivalent to 200 ng/L nicotine) treatment group, T3: 
50  μmol/L
  VE  +  CSE  (equivalent  to  200  ng/L  nicotine) 
treatment group, T4: 100 μmol/L
 VE + CSE (equivalent to 
200 ng/L nicotine) treatment group, T5: 200 μmol/L
 VE + 
CSE (equivalent to 200 ng/L nicotine) treatment group. 
 
Preventive effects of VE on CSE-induced cell apopto-
sis of ELCs 
CSE-induced  apoptosis  of  ELCs  was  markedly 
reduced  with  25  μmol/L  or  higher  doses  of  VE 
treatment (P < 0.05, P < 0.01). Moreover, the apoptosis 
rate  of  ELCs  recovered  to  normal  levels  with  100 
μmol/L or 200 μmol/L VE treatment (P > 0.05). The 
above  results  showed  that  VE  could  significantly 
prevent  or  reverse  CSE-induced  cell  apoptosis;  fur-
thermore,  preventive  effect  improved  with  an  in-
crease of VE dose, indicating a dose-dependent cor-
relation (r=0.937, P<0.05), however, VE alone did not 
cause any changes to the cell apoptosis of ELCs (Fig-
ure 7).  
Preventive effects of VE on CSE-induced DNA damage 
of ELCs 
VE (100 μmol/L) could significantly reduce the 
length of the DNA comet tail of ELCs compared with 
that  in  CSE-treated  group  (P<0.05),  suggesting  that 
VE  treatment  can  prevent  the  CSE-induced  DNA 
damage, but VE alone did not cause any effects to the 
DNA damage of ELCs (Figure 4 A, B). 
Involvement of the mitochondrial pathway in 
CSE-induced apoptosis through cytochrome 
c-mediated caspase activation 
To determine whether CSE induces apoptosis via 
the activation of caspases, a specific peptide substrate 
was  used  to  detect  caspase-3  proteolytic  activity. 
Marked  caspase-3  activation  was  observed  in  ELCs 
after  CSE  (200  ng/L  as  the  equivalent  to  nicotine) 
treatment for 30 h, as shown in Figure 8. This result 
demonstrated that caspase activation was involved in 
CSE-induced cell  apoptosis. VE (100 μmol/L) inter-
vention  significantly  reduced  caspase-3  activity 
compared  with  that  in  the  CSE-treated  group  (P< 
0.05),  while  VE  treatment  alone  did  not  cause  any 
effects (P > 0.05). 
Western blotting analysis revealed an increase in 
cytosolic  cytochrome  c,  which  coincided  with  both 
Bax upregulation and Bcl-2 downregulation in ELCs 
after  CSE  (200  ng/L  as  the  equivalent  to  nicotine) 
treatment for 30 h. Meanwhile, VE (100 μmol/L) in-
tervention decreased cytosolic cytochrome c release, 
reduced the expression of Bax, and promoted the ex-
pression  of  Bcl-2  compared  with  that  in  the 
CSE-treated group (Figure 9). These observations in-
dicated  that  the  mitochondrial  pathway  of  cyto-
chrome c-mediated caspase activation was involved 
in the response of ELCs to cigarette smoke exposure. 
 
 
Figure 7. Preventive effects of VE on CSE-induced cell 
apoptosis of ELCs. VE1, VE2, VE3, VE4 and VE5 refer to VE 
at the dose of 1 μmol/L, 25 μmol/L, 50 μmol/L, 100 μmol/L, 
200 μmol/L, respectively. * P < 0.05, ** P < 0.01 vs control 
group, 
# P < 0.05, 





Figure 8. Activation of caspase-3 by CSE and VE inter-
vention in ELCs. Extracts of whole-cell lysate were ana-
lyzed for caspase activity. Specific substrate for caspase-3 
was used, and the cleavage of the peptide was monitored at 
405 nm. The data represent the mean ± SD from 3 inde-
pendent experiments. * P < 0.05 vs control group, # P < 0.05 
vs CSE group. VE: 100 μmol/L
 VE treatment group, CSE: CSE 
(equivalent to 200 ng/L nicotine) treatment group, CSE+VE: 
100  μmol/L
 VE  +  CSE  (equivalent  to  200  ng/L  nicotine) 





Figure  9.  Release  of  mitochondrial  cytochrome  c  and 
expression of Bax and Bcl-2 in ELCs. The proteins from the 
cytosolic  cell  lysate  (for  cytochrome  c)  and  whole-cell 
lysate (for Bax and Bcl-2) were analyzed by Western blot-
ting. Actin was used as an internal control. The data rep-
resent the mean ± SD from 3 independent experiments. (A) 
The  representative  pictures  for  Western  blotting  in  dif-
ferent groups. (B) Expression of proteins of the relevant 
apoptosis genes in ELCs. * P < 0.05 vs control group, # P < 
0.05 vs CSE group. VE: 100 μmol/L
 VE treatment group, CSE: 
CSE  (equivalent  to  200  ng/L  nicotine)  treatment  group, 
CSE+VE: 100 μmol/L
 VE + CSE (equivalent to 200 ng/L nic-
otine) treatment group. 
 
Discussion 
Cigarette smoke (CS) contains more than 4,500 
chemical compounds, including high concentrations 
of  oxygen  free  radicals  and  nitric  oxide  in  the  gas 
phase and organic compounds such as semiquinone 
radicals in the tar phase. These compounds resulted in 
the generation of reactive oxygen and nitrogen species 
[31-35]. It has been recently demonstrated that CSE 
contains some stable oxidants, i.e., peroxynitrite-like 
reactants,  which  cause  extensive  oxidative  stress 
damage [36, 37]. Since the damage was induced by 
oxidative stress, antioxidants could play a major role 
in protection against CS-related lung damage or dis-
eases.  VE,  a  potent  peroxyl  radical  scavenger,  is  a 
chain-breaking antioxidant that prevents the propa-
gation of free radical damage in biological membranes 
[38],  and  it  may  have  protective  effects  against 
CSE-induced  cytotoxicity  in  the  lung  cells.  The  sig-
nificance  of  VE  has  been  proven  as  a  radical  chain 
breaking antioxidant that can protect the integrity of 
tissues and play an important role in life process, and 
it has been found to possess functions that are inde-
pendent of its antioxidant/radical scavenging ability, 
such as inhibitory effects on protein kinase C, on the 
growth  of  certain  cells  and  on  the  transcription  of 
some  genes,  activation  on  the  expression  of  other 
genes [39]. 
Several studies have evaluated the effects of CS 
on  cell  proliferation  in  lung  fibroblasts,  the  results 
indicated  that  CSE  significantly  inhibited  fibroblast 
proliferation and migration, and induced cellular se-
nescence [14, 16]. Our results showed that CSE could 
produce an obvious inhibitory effect on the survival 
of  ELCs;  furthermore,  this  effect  increases  with  an 
increase  in  CSE  concentration  and  treatment  time, 
indicating dose- and time-dependency of the inhibi-
tory effects. VE could remarkably prevent and reverse 
the CSE-induced inhibitory effects on the growth of 
ELCs. Furthermore, at doses of 100 μmol/L or above 
VE treatment, cell growth recovered to normal level 
and was even better than that in the control group, 
illustrating  that  VE  could  not  only  prevent 
CSE-induced  inhibitory  effects  on  cell  growth  but 
could also significantly promote cell proliferation.  
The inhibitory effects of CSE on cell proliferation 
and the preventive effect of VE on CSE-induced cy-
totoxicity  might  be  closely  correlated  with  the  cell 
cycle. We found that CSE clearly disturbed the cell 
cycle of ELCs, produced a significant decrease in the 
proportion of cells in the S and G2/M phases and an 
obvious  increase  in  the  proportion  of  cells  in  the 
G0/G1 phase.  It  is  suggested  that  CSE  arrested  the 
ELCs at the G0/G1 phase. Nyunoya et al [16] also drew 
a  similar  conclusion.  CSE  severely  disturbed  the 
normal progression of the cell cycle, which might be 
the mechanism underlying CSE-induced inhibition of 
cell  proliferation  and  CSE-induced  apoptosis;  also 
might be the mechanism of tumor formation because 
it is well kwon that the disorder of cell cycle is one of 
the  mechanisms  of  tumor  formation  [14,  16].  We 
found  that  VE  clearly  prevented  and  improved 
CSE-induced  disturbance  of  the  cell  cycle;  further-
more,  the  normal  cell  cycle  was  restored  with  100 
μmol/L VE treatment. The results illustrated that VE 
exhibits  an  obvious  preventive  effect  on  the 




Numerous studies have reported that CSE could 
induce death or apoptosis in different cell lines [17, 18, 
40]. Liu et al reported that CSE only induced DNA 
damage in human bronchial epithelial cells and not 
cell apoptosis [19].The reason about this different ob-
servation might lie in the different CSE doses used in 
the  experiment.  Low  concentrations  of  cigarette 
smoke  induced  DNA  damage  and  repair  without 
leading  to  apoptosis  in  human  bronchial  epithelial 
cells, higher concentrations of cigarette smoke, how-
ever, could induce either apoptosis or necrosis [41]. 
Our results showed that CSE clearly induced apopto-
sis  in  ELCs,  in  a  dose-dependent  manner,  i.e.,  the 
proportion  of  cell  apoptosis  significantly  increased 
with an increase in the CSE concentration. This result 
confirmed to those of other studies [42, 43]. VE could 
remarkably prevent and reverse CSE-induced apop-
tosis  in  a  dose-dependent  manner.  Apoptosis  was 
restored  to  normal  levels  with  200  μmol/L  of  VE 
treatment.  This  result  indicated  that  VE  had  a  pre-
ventive effect on CSE-induced apoptosis.  
Accumulating  evidence  indicated  that  mito-
chondria play a pivotal role in the apoptotic process in 
mammalian  cells  [44].  Activated  effector  caspase-3 
subsequently executed apoptosis by cleaving various 
cellular  substrates  vital  for  cell  survival,  ultimately 
resulting  in  apoptosis  [45].  The  caspase  activation 
events could be initiated by the release of cytochrome 
c from the mitochondria into the cytosol, and this was 
a critical step in the death-signaling cascade [46]. It 
was  the  expression  and  subcellular  translocation  of 
cell  death  initiators  or  repressors  such  as  Bax  and 
Bcl-2 that regulated the release of cytochrome c [47, 
48]. The overexpression of Bcl-2 blocked cytochrome c 
release in response to a variety of apoptotic stimuli 
[49]. In contrast, the upregulation and redistribution 
of  Bax  from  the  cytosol  to  the  mitochondria  could 
promote  the  release  of  cytochrome  c  [50].  The  evi-
dence  from  the  present  study  confirmed  that  CSE 
promoted  ELCs  apoptosis  and  VE  intervention 
yielded the opposite results in which the cytochrome 
c-mediated  caspase  activation  mitochondrial  signal-
ing pathway was involved. 
In  conclusion,  a  primary  culture  of  ELCs  was 
used for the first time to observe the preventive effect 
of  the  antioxidant  VE  on  CSE-induced  cytotoxicity. 
CSE could clearly inhibit the survival of ELCs, disturb 
the  cell  cycle,  promote  cell  apoptosis,  and  induced 
DNA damage. VE possessed a significant antagonistic 
effect on the above effects of CSE. At a certain dose, 
VE  treatment  might  inhibit  or  reverse  the  cytotoxic 
effects of CSE on ELCs. The mechanisms underlying 
CSE-induced cytotoxicity and VE intervention might 
be associated with the mitochondrial pathway of cy-
tochrome c-mediated caspase activation.  
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